DekaBank Deutsche Girozentrale’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14M | Hold |
20,000
| – | – | ﹤0.01% | 839 |
|
|
2025
Q1 | $846K | Hold |
20,000
| – | – | ﹤0.01% | 877 |
|
|
2024
Q4 | $557K | Hold |
20,000
| – | – | ﹤0.01% | 981 |
|
|
2024
Q3 | $559K | Hold |
20,000
| – | – | ﹤0.01% | 993 |
|
|
2024
Q2 | $466K | Hold |
20,000
| – | – | ﹤0.01% | 1019 |
|
|
2024
Q1 | $488K | Sell |
20,000
-7,600
| -28% | -$185K | ﹤0.01% | 1004 |
|
|
2023
Q4 | $659K | Hold |
27,600
| – | – | ﹤0.01% | 984 |
|
|
2023
Q3 | $1.33M | Buy |
27,600
+6,000
| +28% | +$290K | ﹤0.01% | 824 |
|
|
2023
Q2 | $966K | Hold |
21,600
| – | – | ﹤0.01% | 886 |
|
|
2023
Q1 | $812K | Buy |
21,600
+7,600
| +54% | +$286K | ﹤0.01% | 917 |
|
|
2022
Q4 | $747K | Hold |
14,000
| – | – | ﹤0.01% | 952 |
|
|
2022
Q3 | $417K | Buy |
+14,000
| New | +$417K | ﹤0.01% | 1078 |
|
|
2022
Q2 | – | Sell |
-13,500
| Closed | -$197K | – | 1364 |
|
|
2022
Q1 | $197K | Buy |
13,500
+1,200
| +10% | +$17.5K | ﹤0.01% | 1211 |
|
|
2021
Q4 | $261K | Buy |
12,300
+300
| +3% | +$6.37K | ﹤0.01% | 1223 |
|
|
2021
Q3 | $266K | Hold |
12,000
| – | – | ﹤0.01% | 1155 |
|
|
2021
Q2 | $305K | Hold |
12,000
| – | – | ﹤0.01% | 1141 |
|
|
2021
Q1 | $338K | Hold |
12,000
| – | – | ﹤0.01% | 1092 |
|
|
2020
Q4 | $301K | Buy |
+12,000
| New | +$301K | ﹤0.01% | 1120 |
|